Summary: Siemens Healthineers announces U.S. FDA clearance of the Acuson Origin, a cardiovascular ultrasound system powered by AI features, and the AcuNav Lumos 4D ICE catheter. These technologies aim to enhance diagnostic accuracy, procedural efficiency, and patient care in cardiac procedures.

Key Takeaways:

  • FDA Clearance: Siemens Healthineers received FDA clearance for the ACUSON Origin ultrasound system, designed to improve cardiac diagnostics and procedures with advanced AI features.
  • AI-Powered Efficiency: The system provides over 5,600 AI-powered measurements and real-time cardiac view recognition, automating tasks to reduce cognitive workload and improve consistency.

Siemens Healthineers announces U.S. FDA clearance for the Acuson Origin, a new AI-powered cardiovascular ultrasound system.

AI Features and Efficiency in Cardiac Care

The AI features are designed to help physicians perform cardiac procedures more efficiently in the areas of diagnostics, structural heart disease, and electrophysiology. Available exclusively with the ACUSON Origin, the new AcuNav Lumos 4D ICE (intracardiac echocardiography) catheter provides advanced imaging for complex heart procedures.

“With its advanced AI features and potential to enhance diagnostic accuracy as well as patient care, the ACUSON Origin is positioned to reshape healthcare’s approach to cardiovascular imaging,” said David Zollinger, head of cardiovascular ultrasound at Siemens Healthineers. “And the AcuNav Lumos is the latest milestone in our 24-year history with ICE. Since 1999, our ICE catheters have helped more than 2 million patients, reducing the need for anesthesia during procedures.”

The ACUSON Origin addresses cardiovascular patient care, including diagnostic, structural heart, vascular, electrophysiological, and pediatric procedures. It is designed to minimize the cognitive and ergonomic workload of cardiac exams and procedures, allowing for greater consistency, reproducibility, and user efficiency.

AI-Powered Measurements and Imaging Assistance

Its suite of AI-powered features for measurements, view recognition, and imaging assistance builds on the company’s AI development, which dates to the late 1990s. The AI features have been trained on an image database that contains over 2 billion annotated images. The features can save the user time on echocardiography procedures by providing automated measurements with accuracy and reproducibility.

ACUSON Origin is capable of more than 5,600 AI-powered measurements on transthoracic echocardiography (TTE) and transesophageal echocardiography (TEE). The system provides real-time cardiac view recognition. AI Assist, a new feature for TTE, recognizes cardiac structures and automatically positions color and spectral Doppler regions of interest when the transducer makes contact with the chest wall.

Advanced Imaging with AcuNav Lumos 4D ICE Catheter

Several features debuting on the AcuNav Lumos fourth-generation 4D ICE ultrasound catheter are designed to enhance procedural guidance for better patient care. The catheter enables interventional cardiologists and electrophysiologists to treat patients who otherwise would be unable to undergo structural heart interventions, including patients with TEE or general anesthesia contraindications, and patients with tricuspid regurgitation.

The AcuNav Lumos offers improved MPR biplane imaging—with or without an ECG—for more accurate anatomical assessment and device guidance as well as improved leak detection with real-time 4D color Doppler. Three-dimensional calipers label cardiac anatomy and provide accurate 3D measurements.